Contact
Please use this form to send email to PR contact of this press release:
Proteon Therapeutics Announces Increase to Enrollment of Ongoing Phase 3 PATENCY-2 Clinical Trial
TO:
Please use this form to send email to PR contact of this press release:
Proteon Therapeutics Announces Increase to Enrollment of Ongoing Phase 3 PATENCY-2 Clinical Trial
TO: